Mauro Ferrari
Affiliations: | 1991-1998 | Materials Science and Engineering | University of California, Berkeley, Berkeley, CA, United States |
1998-2006 | Biomedical engineering | Ohio State University, Columbus, Columbus, OH | |
2003-2006 | Nanotechnology | National Cancer Institute, Rockville, MD, United States | |
2006- | Molecular Medicine | University of Texas Health Science Center at Houston, Houston, TX, United States | |
2006-2008 | Biochemistry and Molecular Biology | University of Texas Medical Branch, Galveston, TX | |
2006-2010 | Experimental Therapeutics | University of Texas M.D. Anderson Cancer Center | |
2011- | Weill Cornell Medical College, New York, NY, United States | ||
2019- | Pharmaceutics | University of Washington, Seattle, Seattle, WA |
Area:
Biomedical EngineeringWebsite:
https://sop.washington.edu/people/mauro-ferrari/Google:
"Mauro Ferrari"Bio:
https://www.houstonmethodist.org/~/media/pdf/research/unsorted/research/mauroferraricv.ashx?la=en
https://books.google.com/books?id=RQVJAQAAMAAJ
https://books.google.com/books?id=mIpHAQAAMAAJ
Parents
Sign in to add mentorGeorge Carver Johnson | grad student | 1989 | UC Berkeley (E-Tree) | |
(Effective Elastic Properties of Textured Materials) |
Children
Sign in to add traineeDerek Hansford | grad student | University of Washington | |
Tejal A. Desai | grad student | 1998 | UC Berkeley |
Ye Hu | grad student | 2009 | UT Austin |
Guillermo U Ruiz-Esparza | grad student | 2011-2014 | Houston Methodist Hospital, Weill Cornell Medical College (Chemistry Tree) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Goel S, Zhang G, Dogra P, et al. (2020) Sequential deconstruction of composite drug transport in metastatic breast cancer. Science Advances. 6: eaba4498 |
Leonard F, Srinivasan S, Liu X, et al. (2020) Design and in vitro characterization of multistage silicon-PLGA budesonide particles for inflammatory bowel disease. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V |
Hu Z, Nizzero S, Goel S, et al. (2020) Molecular targeting of FATP4 transporter for oral delivery of therapeutic peptide. Science Advances. 6: eaba0145 |
Ruiz-Ramírez J, Ziemys A, Dogra P, et al. (2020) A modeling platform for the lymphatic system. Journal of Theoretical Biology. 110193 |
Lenna S, Bellotti C, Duchi S, et al. (2020) Mesenchymal stromal cells mediated delivery of photoactive nanoparticles inhibits osteosarcoma growth in vitro and in a murine in vivo ectopic model. Journal of Experimental & Clinical Cancer Research : Cr. 39: 40 |
Nizzero S, Li F, Zhang G, et al. (2019) Systematic comparison of methods for determining the in vivo biodistribution of porous nanostructured injectable inorganic particles. Acta Biomaterialia |
Wolfram J, Ferrari M. (2019) Clinical Cancer Nanomedicine. Nano Today. 25: 85-98 |
Kai M, Ziemys A, Liu YT, et al. (2019) Tumor Site-Dependent Transport Properties Determine Nanotherapeutics Delivery and Its Efficacy. Translational Oncology. 12: 1196-1205 |
Corradetti B, Pisano S, Conlan RS, et al. (2019) Nanotechnology and immunotherapy in ovarian cancer: tracing new landscapes. The Journal of Pharmacology and Experimental Therapeutics |
Ziemys A, Yokoi K, Kai M, et al. (2018) Progression-dependent transport heterogeneity of breast cancer liver metastases as a factor in therapeutic resistance. Journal of Controlled Release : Official Journal of the Controlled Release Society |